Pharma

Your Article Summary

See Latest Articles

Watson Launches GELNIQUE(TM) (oxybutynin chloride) Gel 10%, First and Only Topical Gel for Overactive Bladder (OAB)
Watson Pharmaceuticals, 05/22/09

Watson Pharmaceuticals, a leader in generic and specialty branded pharmaceuticals, announced the launch of GELNIQUE gel 10%, first and only topical gel for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency.

Today in Medical Devices/Products...keeping you current

Receive free subspecialty "5-minute updates" via email

Phase III Data Showed Rituxan Plus Chemotherapy Improved Survival in Patients With Most Common Form of Adult Leukemia
Genentech, 12/08/09

New Amgen Scholars Web site Launches to Build a Global Network for Future Scientists
Amgen, 12/04/09

Genzyme Begins Shipping Newly Produced Cerezyme from Allston Plant
Genzyme, 12/02/09

 See all of Medical Devices/Products